Thanks Woldanorf.
My concern was that raising dystrophin showed no more benefit than the placebo group, so that may not be as beneficial to the patient as first expected.
I guess its possible that if inflammation is reduced, raising dystrophin could become more relevant.
Research note, page-91
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.1¢ |
Change
-0.001(1.22%) |
Mkt cap ! $83.97M | |||
| Open | High | Low | Value | Volume |
| 8.3¢ | 8.3¢ | 7.9¢ | $217.9K | 2.697M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 565391 | 8.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.2¢ | 342651 | 4 |
View Market Depth
| Last trade - 13.45pm 14/11/2024 (20 minute delay) ? |
| PER (ASX) Chart |